Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Chemical starting matter for HNF4α ligand discovery and chemogenomics

: Meijer, I.; Willems, S.; Ni, X.; Heering, J.; Chaikuad, A.; Merk, D.

Volltext ()

International journal of molecular sciences 21 (2020), Nr.21, Art. 7895, 11 S.
ISSN: 1422-0067
ISSN: 1661-6596
European Commission EC
H2020; 875510; EFPIA
Zeitschriftenaufsatz, Elektronische Publikation
Fraunhofer IME ()

Hepatocyte nuclear factor 4α (HNF4α) is a ligand-sensing transcription factor and presents as a potential drug target in metabolic diseases and cancer. In humans, mutations in the HNF4α gene cause maturity-onset diabetes of the young (MODY), and the elevated activity of this protein has been associated with gastrointestinal cancers. Despite the high therapeutic potential, available ligands and structure–activity relationship knowledge for this nuclear receptor are scarce. Here, we disclose a chemically diverse collection of orthogonally validated fragment-like activators as well as inverse agonists, which modulate HNF4α activity in a low micromolar range. These compounds demonstrate the druggability of HNF4α and thus provide a starting point for medicinal chemistry as well as an early tool for chemogenomics.